📰 Scientific Program Committee News
Page 3 - Scientific Program Committee News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scientific Program Committee. Real-time updates on events, politics, business and more.
November 23, 2022
November 21, 2022, Cypress, California (PRWEB) November 23, 2022 -- AAGL Global Congress will welcome physicians from all over the world online and live at
October 25, 2022
Mary Kay Inc., one of the world's innovative skincare companies, has announced a new partnership with the European Society for Dermatological Research (ESDR) with its registered office in Geneva, Switzerland
October 21, 2022
Prescription drugs designed to boost cognition in neurodevelopmental disorders do not boost cognitive performance in healthy individuals -- and may even reduce productivity, new research suggests.
October 19, 2022
Cypress, CA (PRWEB) October 19, 2022 -- AAGL Global Congress registration is filling at a record-breaking pace as the global association prepares to welcome
October 14, 2022
/PRNewswire/ -- Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve peoples health and the quality of patients...
October 6, 2022
/PRNewswire/ -- Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of...
September 6, 2022
Lucknow, Sep 6 (IANS) Eminent scientist Radha Rangarajan is the new director of CSIR-Central Drug Research Institute (CDRI), Lucknow.
September 6, 2022
Eminent scientist Radha Rangarajan is the new director of CSIR-Central Drug Research Institute (CDRI), Lucknow.
July 13, 2022
The Society of Cardiovascular Computed Tomography (SCCT) has released an update on the device manufacturers set to display their latest technologies at the 2022 Annual Scientific Meeting (SCCT2022) being held in Las Vegas July 15 – 17.
June 2, 2022
Targeting a protein complex that inhibits lipoprotein lipase with a monoclonal antibody lowers both triglycerides and LDL cholesterol while increasing HDL cholesterol, suggests an early-stage trial.